InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Englese Thomas, Directeur Commercial. Officer active across 1 company, notably Aziyo Biologics, INC.. Aggregated, 4 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €25k. History available since 14 December 2021. The latest transaction was filed on 8 March 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Englese Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
937 shares0Class A Common StockSEC:0001415889-23-004626:0
15,390 sharesClass A Common StockSEC:0001415889-22-009538:0
938 shares0Class A Common StockSEC:0001415889-22-002868:0
4,580 shares@ US$6.10100.0% of flowClass A Common StockSEC:0001415889-21-005960:0
Canonical exit: 14 Mar 2022 (T+90)
4 of 4 declarations
About Englese Thomas
Englese Thomas is the Chief Commercial Officer at AZIYO BIOLOGICS, INC. In this role, he is responsible for commercial strategies and sales development. His expertise in marketing and sales is crucial for the growth and success of Azio.
